Connection

Peter Verhamme to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Peter Verhamme has written about Antibodies, Monoclonal, Humanized.
Peter Verhamme
Connection Strength
0.351
Antibodies, Monoclonal, Humanized
  1. Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation. Eur J Heart Fail. 2019 01; 21(1):129-131.
    View in: PubMed
    Score: 0.161
  2. The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays. Int J Lab Hematol. 2018 Aug; 40(4):442-447.
    View in: PubMed
    Score: 0.154
  3. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med. 2017 08 03; 377(5):431-441.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.